Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 460
6
Diseases
4
Unique genes
0.325
Avg. similarity score
Gm2 gangliosidosis
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Gm2 gangliosidosis
Tay-sachs disease
Beta-hexosaminidase a deficiency
Gm2-gangliosidosis, several forms, tay-sachs disease
Hex a pseudodeficiency
Hexosaminidase activator deficiency
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Gm2 gangliosidosis | 5 | 5 | 3 |
| Tay-sachs disease | 5 | 5 | 3 |
| Beta-hexosaminidase a deficiency | 4 | 4 | 1 |
| Gm2-gangliosidosis, several forms, tay-sachs disease | 4 | 4 | 1 |
| Hex a pseudodeficiency | 4 | 4 | 1 |
| Hexosaminidase activator deficiency | 2 | 2 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HEXA | 5 / 6 | Beta-hexosaminidase a deficiency, Gm2 gangliosidosis, Gm2-gangliosidosis, several forms, tay-sachs disease, Hex a pseudodeficiency and 1 more |
| GM2A | 3 / 6 | Gm2 gangliosidosis, Hexosaminidase activator deficiency, Tay-sachs disease |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Glycosphingolipid metabolism | Reactome | 3 / 46 | 196× | 2.10e-7 | 1.07e-5 ✓ sig. |
| Sphingolipid metabolism | KEGG | 3 / 54 | 167× | 3.43e-7 | 1.64e-5 ✓ sig. |
| Lysosome | KEGG | 3 / 133 | 67.7× | 5.27e-6 | 1.71e-4 ✓ sig. |
| Hyaluronan uptake and degradation | Reactome | 2 / 12 | 500× | 5.49e-6 | 1.77e-4 ✓ sig. |
| Keratan sulfate degradation | Reactome | 2 / 13 | 462× | 6.48e-6 | 2.04e-4 ✓ sig. |
| CS/DS degradation | Reactome | 2 / 14 | 429× | 7.56e-6 | 2.32e-4 ✓ sig. |
| Glycosphingolipid biosynthesis - ganglio series | KEGG | 2 / 15 | 400× | 8.72e-6 | 2.60e-4 ✓ sig. |
| Glycosphingolipid biosynthesis - globo and isoglobo series | KEGG | 2 / 16 | 375× | 9.97e-6 | 2.91e-4 ✓ sig. |
| Other glycan degradation | KEGG | 2 / 18 | 334× | 1.27e-5 | 3.55e-4 ✓ sig. |
| Glycosaminoglycan degradation | KEGG | 2 / 19 | 316× | 1.42e-5 | 3.90e-4 ✓ sig. |
| Amino sugar and nucleotide sugar metabolism | KEGG | 2 / 38 | 158× | 5.83e-5 | 1.23e-3 ✓ sig. |
| Various types of N-glycan biosynthesis | KEGG | 2 / 43 | 140× | 7.48e-5 | 1.50e-3 ✓ sig. |
| Defective HEXA causes GM2G1 | Reactome | 1 / 1 | 3,003× | 3.33e-4 | 4.88e-3 ✓ sig. |
| Defective HEXB causes GM2G2 | Reactome | 1 / 1 | 3,003× | 3.33e-4 | 4.88e-3 ✓ sig. |
| Neutrophil degranulation | Reactome | 2 / 480 | 12.5× | 9.06e-3 | 5.36e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| ganglioside catabolic process | GO:0006689 | 3 / 8 | 1,752× | 2.06e-10 | 5.84e-8 ✓ sig. |
| lipid storage | GO:0019915 | 3 / 32 | 438× | 1.82e-8 | 2.97e-6 ✓ sig. |
| neuromuscular process controlling balance | GO:0050885 | 3 / 53 | 264× | 8.60e-8 | 1.11e-5 ✓ sig. |
| dermatan sulfate proteoglycan catabolic process | GO:0030209 | 2 / 4 | 2,336× | 2.06e-7 | 2.32e-5 ✓ sig. |
| oligosaccharide catabolic process | GO:0009313 | 2 / 12 | 779× | 2.27e-6 | 1.68e-4 ✓ sig. |
| glycosaminoglycan metabolic process | GO:0030203 | 2 / 12 | 779× | 2.27e-6 | 1.68e-4 ✓ sig. |
| hyaluronan catabolic process | GO:0030214 | 2 / 16 | 584× | 4.12e-6 | 2.71e-4 ✓ sig. |
| sexual reproduction | GO:0019953 | 2 / 17 | 550× | 4.67e-6 | 3.01e-4 ✓ sig. |
| carbohydrate derivative metabolic process | GO:1901135 | 2 / 18 | 519× | 5.25e-6 | 3.29e-4 ✓ sig. |
| N-glycan processing | GO:0006491 | 2 / 19 | 492× | 5.87e-6 | 3.60e-4 ✓ sig. |
| lysosome organization | GO:0007040 | 2 / 65 | 144× | 7.12e-5 | 2.40e-3 ✓ sig. |
| myelination | GO:0042552 | 2 / 73 | 128× | 8.99e-5 | 2.86e-3 ✓ sig. |
| locomotory behavior | GO:0007626 | 2 / 99 | 94.4× | 1.66e-4 | 4.43e-3 ✓ sig. |
| positive regulation of termination of DNA-templated transcription | GO:0060566 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |
| male courtship behavior | GO:0008049 | 1 / 1 | 4,672× | 2.14e-4 | 5.31e-3 ✓ sig. |